Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 2
2006 6
2007 9
2008 5
2009 14
2010 19
2011 17
2012 12
2013 10
2014 8
2015 8
2016 13
2017 4
2018 12
2019 11
2020 15
2021 16
2022 16
2023 18
2024 12
2025 17
2026 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

216 results

Results by year

Filters applied: . Clear all
Page 1
Trabectedin plus CD13-targeted tissue factor tTF-NGR against advanced relapsed or refractory soft tissue sarcoma: translational data, clinical safety and efficacy.
Hessling K, Brand C, Schwöppe C, Gerwing M, Pavelka S, Berdel AF, Hintelmann H, Hamacher R, Müller-Tidow C, Egerer G, Hartmann W, Grünewald I, Lindner LH, Di Gioia D, Hecker JS, Maurer S, Pink D, Fried M, Zapata Bonilla SA, Scheuble AM, Lordick F, Ivanyi P, Fobker M, Lenz G, Gerss J, Kessler T, Berdel WE, Schliemann C. Hessling K, et al. Among authors: gerss j. Sci Rep. 2026 Feb 19;16(1):7389. doi: 10.1038/s41598-026-40362-4. Sci Rep. 2026. PMID: 41714802 Free PMC article. Clinical Trial.
Randomised controlled study investigating standard dose continuous renal replacement therapy (CRRT) versus low-dose CRRT in critically ill patients with acute kidney injury (AKI): study protocol for a prospective, randomised, controlled, international, multicentre trial (the 'Ketzerei' trial).
Strauß C, Sadjadi M, von Groote T, Booke H, Schöne LM, Hegner C, Wempe C, Meersch M, Gerss J, Bernard A, Haeberle HA, Rosenberger P, Rahmel T, Unterberg M, Adamzik M, Arndt C, Wulf H, Romagnoli S, Bonizzoli M, Mandarano R, Premuzic V, Andrade L, Smolentzov I, Bagshaw SM, Chawla L, Zarbock A. Strauß C, et al. Among authors: gerss j. BMJ Open. 2025 Sep 22;15(9):e105459. doi: 10.1136/bmjopen-2025-105459. BMJ Open. 2025. PMID: 40983574 Free PMC article.
Malignant Rhabdoid Tumors of the Liver Are Associated With Inferior Outcomes Compared to Other Extracranial Rhabdoid Tumors.
Bühner S, Gastberger K, Tüchert-Knoll S, Fincke VE, Johann PD, Melchior P, Teleshova M, Kachanov D, Shcherbakov A, Schmid I, Roka K, Siebert R, Vokuhl C, Gerss J, Fuchs J, Furtwängler R, Frühwald MC. Bühner S, et al. Among authors: gerss j. Pediatr Blood Cancer. 2025 Dec;72(12):e32062. doi: 10.1002/pbc.32062. Epub 2025 Sep 19. Pediatr Blood Cancer. 2025. PMID: 40974093
Enhancing cardiorespiratory fitness and quality of life in high-grade glioma through an intensive exercise intervention during chemotherapy: Proof of concept.
Jost-Engl J, Ketter R, Brandt R, Völker K, Gerß J, Jetschke K, Weiss Lucas C, Baumann FT, Lepper PM, Urbschat S, Stummer W, Wiewrodt R, Wiewrodt D; MMH Trial Investigators. Jost-Engl J, et al. Among authors: gerss j. Neuro Oncol. 2025 Nov 1;27(11):2977-2990. doi: 10.1093/neuonc/noaf176. Neuro Oncol. 2025. PMID: 40726159 Free PMC article.
Effects of an extended therapeutic strategy versus standard-of-care therapy on persistent acute kidney injury in high-risk patients after major surgery: study protocol for the randomised controlled single-centre PrevProgAKI trial.
Sadjadi M, Strauß C, von Groote T, Booke H, Schöne LM, Sauermann L, Wempe C, Gerss J, Kellum J, Meersch M, Zarbock A. Sadjadi M, et al. Among authors: gerss j. BMJ Open. 2025 May 6;15(5):e097333. doi: 10.1136/bmjopen-2024-097333. BMJ Open. 2025. PMID: 40328648 Free PMC article.
216 results